Merck & Co's Frazier: International Business Is Only Scratching The Surface
Merck & Co’s sales and EPS grow by double digits in the first quarter, with the performance of Keytruda, and growth in non-US markets, a feature of the three months.
Merck & Co’s sales and EPS grow by double digits in the first quarter, with the performance of Keytruda, and growth in non-US markets, a feature of the three months.